Exempt Chemical Preparations Under the Controlled Substances Act
DEA has approved or denied exempt chemical preparations applications from March 2023 to March 2025, affecting hemp-derived THC and other cannabinoid products that may lose exempt status.
Aforeworn detected this change in the Cannabis & Hemp Operators space on July 5, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Hemp-derived THC brands and processors/manufacturers using exempt chemical preparations should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediately upon publication (July 1, 2025); no grace period specified.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Cannabis & Hemp Operators continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
DEA published a list of approved and denied exempt chemical preparations, potentially removing certain hemp-derived cannabinoid products from the exemption, making them subject to CSA controls.
Who it affects
Hemp-derived THC brands and processors/manufacturers using exempt chemical preparations
What you must do
Review the list to determine if your products are affected; if denied, cease distribution and seek legal counsel.
Deadline
Immediately upon publication (July 1, 2025); no grace period specified.
Never miss a change like this again
Aforeworn watches Cannabis & Hemp Operators around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Cannabis & Hemp Operators
- Oregon Liquor and Cannabis Commission : Marijuana and Hemp (Cannabis) : Marijuana and Hemp (Cannabis) : State of Oregon
- Rulemaking - Department of Cannabis Control
- Federal Acquisition Regulation: List of Domestically Nonavailable Articles
- Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Food and Drug Administration's Adverse Event and Product Experience Reporting Program
- Supplemental Disaster Relief Program (SDRP) Stage 1